跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MICAFUNGINA XELLIA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MICAFUNGINA XELLIA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
MICAFUNGINA XELLIA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Xellia Pharmaceuticals Aps
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 10, 2020
Approval ID
e235bef16d5c1ecb
Company
Xellia Pharmaceuticals Aps
Type
Standard
Approval Details
Approval Id
e235bef16d5c1ecb
Drug Cima Aemps Name
MICAFUNGINA XELLIA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
84981
Holder Company Name
Xellia Pharmaceuticals Aps
Marketing Company Name
Sun Pharma Laboratorios S.L.
Holder Company Detail Path
/organization/xellia-pharmaceuticals-aps
Authorization Date
2020-06-10
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
50 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Xellia Pharmaceuticals Aps
Company Detail Path
/organization/xellia-pharmaceuticals-aps
Company Information
Pharmaceutical Company Name
Xellia Pharmaceuticals ApS
Country Name
Denmark
City Name
københavn s,hovedstaden,country_dk
Address
Dalslandsgade 11
Website
http://www.xellia.com
Active Ingredients
MICAFUNGINA SODICA
50,9 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 10, 2020
Approval ID
e235bef16d5c1ecb
Type
Standard
Back to CIMA-AEMPS Approvals